万维书刊网微信二维码

扫微信,关注编辑QQ!

您的位置:万维书刊网 >>sci/e期刊大全 >>医药卫生>>五官科学

Ophthalmologica(研究方向:眼科学) (官网投稿)

简介
  • 期刊简称待设置
  • 参考译名待设置
  • 核心类别 外文期刊,
  • IF影响因子待设置
  • 自引率待设置
  • 主要研究方向待设置

主要研究方向:

等待设置主要研究方向
待设置

Ophthalmologica(双月刊),创刊于1938年,出版国家为瑞士。自1899年以来,Ophthalmologica已经成为临床和实验眼科国际工作的经常引用的指南。它包含了一系列以患者为导向的文章,涵盖眼病的病因学,诊断技术以及医疗和外科治疗的进步,特别强调视网膜疾病。除原创论文外,眼科学还定期及时进行评估,以便让读者了解情况并更新。
征稿信息

万维提示:

1、投稿方式:在线投稿。

2、期刊官网:

http://www.karger.com/Journal/Home/224269

3、期刊投稿:

https://mc.manuscriptcentral.com/oph

4、官网邮箱:oph@karger.com

5、官网电话:+41 61 306 1573

5、信息说明:本刊信息来源于网络,包括 SCI 收录核心期刊,增补期刊,期刊收录数据每年进行更新。本站是公益性网站,为网友投稿提供免费服务,由于受相关约束,我们不能提供相关期刊的影响因子、JCR期刊分区等数据供大家参考,造成不便,敬请谅解。

2017323日星期四

                      

 

Instructions to Authors

 

 

Submission

 

Original papers and reviews written in English are considered for publication. Manuscript should be submitted online

 

Online Manuscript Submission

 

Should you experience any problems with your submission, please contact the Editorial Office at:

 

oph@karger.com

 

Prof. S. Wolf

S. Karger AG

Editorial Office 'Ophthalmologica'

P.O. Box

CH–4009 Basel (Switzerland)

Tel +41 61 306 1573

Fax +41 61 306 1434

 

Conditions

 

All manuscripts are subject to editorial review.

 

Manuscripts are received with the explicit understanding that they are not under simultaneous consideration by any other publication.

 

A cover letter with the name, address, and telephone and telefax numbers of the corresponding author must accompany each manuscript. This letter must include a statement that affirms that all authors concur with the submission.

 

Submission of an article for publication implies transfer of the copyright from the author to the publisher upon acceptance. Accepted papers become the permanent property of 'Ophthalmologica'; and may not be reproduced by any means, in whole or in part, without the written consent of the publisher.

 

For legal reasons, we must receive your 'Submission Statement' with your original (hand-written) signature. Please download, print, sign and either fax or scan it to make it legally binding.

 

It is the author's responsibility to obtain permission to reproduce illustrations, tables, etc. from other publications.

 

Conflicts of Interest

 

Authors are required to disclose any sponsorship or funding arrangements relating to their research and all authors should disclose any possible conflicts of interest. Conflict of interest statements will be published at the end of the article.

 

Ethics

 

Published research must comply with the guidelines for human studies and animal welfare regulations. Authors should state that subjects have given their informed consent and that the study protocol has been approved by the institute's committee on human research. Further, they should also state that animal experiments conform to institutional standards.

 

Plagiarism Policy

 

Whether intentional or not, plagiarism is a serious violation. We define plagiarism as a case in which a paper reproduces another work with at least 25% similarity and without citation.

If evidence of plagiarism is found before/after acceptance or after publication of the paper, the author will be offered a chance for rebuttal. If the arguments are not found to be satisfactory, the manuscript will be retracted and the author sanctioned from publishing papers for a period to be determined by the responsible Editor(s).

 

Types of Papers

 

Editorial

Original Paper

Review

New Technologies in Ophthalmology

Letter to the Editor

EURETINA Lecture

Ophthalmologica Lecture

 

Reviews

 

Reviews are either invited, or may be submitted for consideration. Invited reviews, if accepted, are not subject to page charges. The recommended length is 6 printed pages (approx. 15 double-spaced manuscript pages).

 

Mini Reviews

 

Mini Reviews should contain an easy-to-read literature overview on a specific topic. Papers are either invited or may be submitted for consideration. Only concise articles of no more than 2 printed pages (approx. 6 double-spaced manuscript pages), including an abstract of max. 200 words and references, will be accepted. Please submit your mini review online.

 

Letter to the Editor

 

Letters are only accepted if they directly concern articles previously published in this journal and clinical subjects related to the matters discussed. The editor reserves the right to submit copies of such letters to the authors of the articles concerned prior to publication in order to permit them to respond in the same issue of the journal. Letters should have a maximum of one printed page (350–420 words, up to 8 references).

 

 

Arrangement

 

Title page: The first page of each paper should indicate the title, the authors’ names, the institute where the work was conducted, and a short title for use as running head.

 

Full address: The exact postal address of the corresponding author complete with postal code must be given at the bottom of the title page. Please also supply phone and fax numbers, as well as e-mail address.

 

Key words: Please supply 3–10 key words in English that reflect the content of the paper.

 

Abstract: Each paper needs an abstract in English of not more than 150 words.

The abstract is of utmost importance. It should contain the following information: purpose of the study, procedures, results, conclusions and message of the paper.

 

Footnotes: Avoid footnotes.

 

Tables and illustrations: Tables and illustrations (both numbered in Arabic numerals) should be sent in separate files. Tables require a heading and figures a legend, also in a separate file. Due to technical reasons, figures with a screen background should not be submitted. When possible, group several illustrations in one block for reproduction (max. size 180 x 223 mm). Black and white half-tone and color illustrations must have a final resolution of 300 dpi after scaling, line drawings one of 800–1,200 dpi.

 

 


投稿问答最小化  关闭